The text discusses a study that explored the relationship between clinicians' regulatory focus (prevention vs. promotion) and their adherence to hypertension (HTN) guidelines, specifically regarding monthly follow-up visits for patients with uncontrolled blood pressure. The study used data from the Blood Pressure Visit Intensification Study and assessed clinician focus, attitudes towards guidelines, and patient outcomes. Results indicated that clinicians with a prevention focus were more likely to adhere to the guidelines compared to those with a promotion focus. The study highlighted the importance of considering clinician behavior and regulatory focus in guideline adherence. Limitations and implications for future research were also discussed, suggesting that Regulatory Focus Theory could be valuable in understanding variations in guideline adherence in clinical settings. The study provides a framework for further investigations into the role of regulatory focus in clinical practice and guideline adherence.